News

Search:

New Portable Anti-Counterfeiting Technology Promises 'Paradigm Shift'

0 Likes

The US Pharmacopoeia (USP) has developed a new technology that holds the promise of detecting substandard and counterfeit medicines with greater accuracy, sensitivity and reliability than other Read More...

Tags:

Anti-Counterfeit

Counterfeit Medicines

PharmaCheck

USP

After Counterfeit Avastin Infiltrates Supply Chain, FDA Goes After Doctors

1 Likes

The US Food and Drug Administration (FDA) is going after doctors in an attempt to protect the pharmaceutical supply chain from more instances of counterfeit medicines, reports Medscape News.There have Read More...

Tags:

Anti-Counterfeit

Avastin

Bevacizumab

Counterfeit

Distributors

Doctors

FDA

Hamburg

Prescriptions

Wholesalers

Indian Task Force Recommends Adoption of Authentication System for Pharmaceuticals

0 Likes

Taking a page out of the anti-counterfeiters’ playbook, a high-level Indian task force has recommended the adoption of verification technology and mobile text messaging authentication for medicines Read More...

Tags:

Africa

Anti-Counterfeit

Counterfeit

drug

Ghana

India

Kenya

Pedigree

Pharmaceutical

SMS

Task Force

Union Health Ministry

Woodcock Calls for Prescription Drug Tracking System

0 Likes

The US Food and Drug Administration (FDA) is calling for a prescription drug tracking system to ensure the pharmaceutical supply chain’s integrity, reports The Financial Times.Janet Woodcock, director Read More...

Tags:

Anti-Counterfeit

Counterfeit

Counterfeiting

drug

FDA

PDUFA

Pharmaceutical

Supply Chain

Testify

Woodcock

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Most Viewed
Most Popular

Most Viewed

Public Warms to FDA in Recent Gallup Poll 28 May 2013
FDA Finalizes Changes to Orphan Drug Regulation, With Emphasis on Clarifying Existing Policies 11 June 2013
Warning Letter to Company Cites Low Supplies of Toilet Paper 15 May 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars 30 April 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA 29 April 2013
Interview: FDA's UDI Architect Jay Crowley on the Agency's Approach to UDI and Pending Changes 2 May 2013
New Legislation Seeks Creation of Provisional Approval Pathway for New Drugs 23 May 2013
New FDA Draft Guidance Aims to Clarify Compassionate Use Process 9 May 2013

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

New Portable Anti-Counterfeiting Technology Promises 'Paradigm Shift'

After Counterfeit Avastin Infiltrates Supply Chain, FDA Goes After Doctors

Indian Task Force Recommends Adoption of Authentication System for Pharmaceuticals

Woodcock Calls for Prescription Drug Tracking System

Get RF Today